KENNETT SQUARE, Pa., Sept. 20, 2017 -- Genesis HealthCare today announced that Tom DiVittorio, Genesis’ Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 3:00 P.M. Eastern Time. The conference is being held at the InterContinental New York Barclay Hotel in New York.
A live webcast and replay of the Company’s presentation will be available on the Company’s website at www.genesishcc.com/investor-relations.
About Genesis HealthCare
Genesis HealthCare (NYSE:GEN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation’s largest post-acute care providers with more than 450 skilled nursing centers and assisted/senior living communities in 30 states nationwide. Genesis subsidiaries also supply rehabilitation and respiratory therapy to approximately 1,700 healthcare providers in 46 states, the District of Columbia and China. References made in this release to “Genesis,” “the Company,” “we,” “us” and “our” refer to Genesis HealthCare and each of its wholly-owned companies. Visit our website at www.genesishcc.com.
Investor Contact:
Genesis HealthCare
Lori Mayer
610-925-2000


Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



